Christobel Selecky Immunity Bio, Inc. (IBRX) insider trading activity

IBRX Quotes by TradingView

Christobel Selecky is Director of ImmunityBio, Inc.. Currently has a direct ownership of 0 shares of IBRX, which is worth approximately $0. The most recent transaction as insider was on Jan 20, 2026, when has been sold 25,000 shares (Common Stock) at a price of $7.51 per share, resulting in proceeds of $187,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Christobel Selecky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2026
SELL
Open market or private sale
$187,750 $7.51 p/Share
25,000 Reduced 100.0%
0 Common Stock
Jan 20 2026
BUY
Exercise of conversion of derivative security
$74,500 $2.98 p/Share
25,000 Added 50.0%
25,000 Common Stock
Jan 16 2026
SELL
Open market or private sale
$250,000 $5.0 p/Share
50,000 Reduced 100.0%
0 Common Stock
Jan 16 2026
BUY
Exercise of conversion of derivative security
$149,000 $2.98 p/Share
50,000 Added 50.0%
50,000 Common Stock
CS

Christobel Selecky

Director
San Diego, CA

Track Institutional and Insider Activities on IBRX

Follow ImmunityBio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBRX shares.

Notify only if

Insider Trading

Get notified when an Immunity Bio, Inc. insider buys or sells IBRX shares.

Notify only if

News

Receive news related to ImmunityBio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IBRX